Medication Alert for Pediatric Rheumatology Families (July 2022)
July 2022 Update: Medication Alert Dear Community, Please find below an important message from our Medical Advisory Committee on behalf of Canadian Pediatric Rheumatologists. ***MEDICAL ADVISORY UPDATE*** July 2022 Re: Actemra (tocilizumab) Shortage There is a shortage of the subcutaneous form of Actemra (tocilizumab) in Canada. This is likely to last several weeks at [...]